The Stat3-sufficient CD103+ cDC1 vaccine restrained bilateral mammary tumor growth (Figure 2A,B), consistent with our prior observations in murine melanoma and osteosarcoma models [20]. This evidence concerns the gene STAT3 and breast cancer.